Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80% of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.
Team offers an open solution to improving research reproducibility
